Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2324181
Max Phase: Preclinical
Molecular Formula: C18H24N2O
Molecular Weight: 284.40
Molecule Type: Small molecule
Associated Items:
ID: ALA2324181
Max Phase: Preclinical
Molecular Formula: C18H24N2O
Molecular Weight: 284.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)c1ccc(CNC23CC4CC(CC(C4)C2)C3)cc1
Standard InChI: InChI=1S/C18H24N2O/c19-17(21)16-3-1-12(2-4-16)11-20-18-8-13-5-14(9-18)7-15(6-13)10-18/h1-4,13-15,20H,5-11H2,(H2,19,21)
Standard InChI Key: LBIPMZUTPHVVHZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 284.40 | Molecular Weight (Monoisotopic): 284.1889 | AlogP: 2.84 | #Rotatable Bonds: 4 |
Polar Surface Area: 55.12 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.82 | CX LogP: 2.47 | CX LogD: 0.12 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.89 | Np Likeness Score: -0.76 |
1. Wang J, Ma C, Wang J, Jo H, Canturk B, Fiorin G, Pinto LH, Lamb RA, Klein ML, DeGrado WF.. (2013) Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus., 56 (7): [PMID:23437766] [10.1021/jm301538e] |
Source(1):